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The Value of Patient-administered Depression Rating Scale 
in Detecting Cognitive Deficits in Depressed Patients
Charles Lung-Cheng Huang
Abstract
Background: The aims of this study was to clarify how accurate 
the depressed patients perceive their cognitive symptoms, and ver-
ify the appropriateness of the depressive rating scales in evaluating 
cognitive deficits in major depressive disorder (MDD) patients.
Methods: The subjects consisted of 19 well-characterized medica-
tion-free patients with MDD and 19 healthy volunteers. The clinical 
and neuropsychological assessments, including Hamilton Rating 
Scale  for  Depression  (HAM-D),  Taiwanese  Depression  Ques-
tionnaire (TDQ), Finger Tapping Test, Wechsler Memory Scale-
Revised,  Stroop  Color-Word Test,  and  Continuous  Performance 
Test, were administered at the time of recruitment and repeated six 
months after treatment.
Results:  Depressed patients exhibited significant impairment in 
several neurocognitive domains. Neurocognitive impairment was 
correlated with both the affective and somatic factors, but not with 
the cognitive factors of TDQ. The similar results were shown after 
6-month treatment.
Conclusions:  Our results suggest that the MDD patients do not 
perceive their cognitive dysfunction correctly. The depression rat-
ing scales, especially the patient-administered scale, need to be 
validated for measuring neurocognitive deficits of MDD patients in 
the future, if cognitive component is suspected as one of the major 
domains of self-rating scale.
Keywords:  Major depressive disorder; Cognitive deficits; Depres-
sion rating scale
Introduction
There  is  growing  evidence  of  significant  impairment  in 
neurocognitive functions in major depressive disorder [1]. 
Depression-related disturbances of cognitive function have 
been demonstrated in a range of domains, including attention 
[2-4], memory [5, 6], executive functions [7, 8], and psy-
chomotor functions [9]. However, findings to date are varied 
[10] with many factors potentially contributing to inconsis-
tencies between studies, including age, hospitalization, se-
verity and subtype of depression, and most importantly, the 
effect of psychotropic medication [11].
Although cognitive deficits are a common and potential-
ly debilitating feature of major depressive disorder (MDD), 
such cognitive impairments are seldom measured with ob-
jective methods as a clinical routine. There are only limited 
items that pertain to neurocognitive impairments in the most 
widely used depression rating scales, for example, the Ham-
ilton Depression Rating Scale [12] and the Beck Depression 
Inventory [13]. Although a recently developed depression 
questionnaire tried to incorporate more comprehensive cog-
nitive items [14, 15], the validity concerning the neurocogni-
tive domain of depression has not yet been confirmed.
By testing a well-characterized group of medication-free 
patients with non-psychotic, unipolar major depressive epi-
sodes on a comprehensive neurocognitive test battery; this 
study aims to explore the correlation between the neurocog-
nitive deficits and the depressive symptoms. By shedding 
some light on how accurate the depressed patients perceive 
their cognitive symptoms, we may be able to verify the ap-
propriateness of the depression rating scales in evaluating 




Patients with non-psychotic MDD were recruited from the 
outpatient clinic of a general hospital. The entry criteria in-
cluded: (1) aged 18 - 65 years and able to communicate with 
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speech or writing; (2) fulfilling DSM-IV criteria for a cur-
rent major depressive episode and free of previous manic/
hypomanic/mixed episodes; (3) entirely psychotropic med-
ication-free currently and for at least six weeks before re-
cruitment; (4) having scored at least 16 on the Hamilton De-
pression Rating Scale (17-item); (5) except for MDD, free of 
any concurrent or past axis I or axis II psychiatric disorder, 
including dementia; (6) free of neurological diseases, illicit 
substance abuse or dependence as determine by clinical his-
tory and examination.
A total of 19 healthy volunteers were recruited from the 
community by advertisement. These volunteers were inter-
viewed by a senior psychiatrist using the Chinese version 
of the Mini International Neuropsychiatric Interview [16] to 
exclude individuals with mental illnesses. 
All  subjects  signed  informed  consent  statement.  The 
study protocol was approved by local Ethical Committee for 
Human Research. 
The demographic data and medical information of sub-
jects were collected, and the clinical and neuropsychologi-
cal assessments were administered at the time of recruitment 







Factor 1 : Cognitive
3. I felt more agitated than before .46  .07 -.09
9. I felt upset .64 -.18  .19
10. I had poor memory .63 -.02  .04
11. I could not concentrate when doing things .50 -.11  .01
12. I was slower in thinking and doing things than before
 .68 .04   -.22
13. I felt less confident than before .74  .16 -.31
14. I tended to look at the dark side of everything .64  .10 -.19
15. I felt miserable and even want to die .43 -.02  .18
18. I felt worthless .65 -.38  .63
Cronbach’s α .86
Factor 2: Affective
1. I often felt like crying -.14 .40 -.18
2. I felt blue and depressed  .24 .89 -.52
5. I had poor appetite  .05 .50  .37
7. I felt uneasy、uncomfortable -.13 .64  .32
8. I felt tired and weak (“Xu”, “mo wan qi”)  .23 .68 -.11
16. I lost interest in everything  .32 .48  .13
17. I felt sick. (Headache, dizziness, palpitation, or abdominal distress)  .00 .59  .39
Cronbach’s α .95
Factor 3: somatic
4. I had trouble in sleeping. …… -.12 .15 .72
6. I frequently had chest tightness(“sim-guan-tau-bang-bang”) -.25 .36 .63
Cronbach’s α
.87
Table 1. The factor Structure and Lodgings and Factors Cronbach’s α for the TDQ
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cal and neuropsychological assessments are as follow:
Clinical assessments
1.   Hamilton Rating Scale for Depression (HAM-D): 
The 17-item HAM-D is a clinician-rated scale. It is the most 
widely used depression scale in both clinical and research 
settings [12].
2.  Taiwanese Depression Questionnaire (TDQ): The 18-
item TDQ is a patient-administered measure of depression. It 
is a culturally relevant questionnaire, which is adaptable for 
screening patients with depression in local communities. The 
TDQ is designed to collect data representative of the past 
seven days, and the cut-off score is 19 [14].
Neuropsychological assessments
Major Depression Normal Controls
Z Sig.
Mean ± SD N Mean ± SD N
Sex
Male 5 10 .09
Female 14 9
Educational level
Below junior high school 4 0 .11
Above junior high school 15 19
Marital status
  Married  8 12 .33
  Single 11 7
Age 33.16 ± 9.77 19 36.05 ± 7.91 19 -.86 .40
HRSD-17 21.47 ± 5.00 19 0.33 ± 0.76 19 -5.35 **
WMS-R .
Verbal MEM.I 80.08 ± 18.06 19 93.25 ± 10.76 19 -2.38 *
Visual MEM.I 87.58 ± 24.13 19 115.25 ± 13.95 19 -2.71 **
General MEM.I 84.42 ± 22.84 19 100.00 ± 9.38 19 -2.43 *
Attention/Concentration 102.42 ± 8.71 19 101.14 ± 10.25 19 -.77 .45
Delayed Recall I 90.07 ± 19.13 19 108.07 ± 11.99 19 -2.86 **
FTT
Dominant hand 35.63 ± 14.86 19 61.46 ± 10.63 19 -3.81 **
SCWT 
Test time 118.8 ± 76.87 19 70.85 ± 20.27 19 -2.42 *
CPT
d’ MASKED 3.83 ± .91 19 3.70 ± .91 19 -.41 .71
Table 2. Demographic Data and Neuropsychological Measures for Patients and Controls
*p < 0.05 (two-tailed);  **p < 0.01 (two-tailed). aHAM-D-17: 17-item Hamilton Rating Scale for Depression; WMS-R: Wechsler Memory 
Scale–Revised; CPT: Continuous Performance Test; FTT: Finger Tapping Test, SCWT: Stroop color-word test. bMann-Whitney U test 
was used to compare the ages and variables of cognitive measurement in both groups. Cross table chi-square was used to compare 
the sex, education level, and marital status. cSignificance at the study-wise type I error rate of 0.05 (2-tailed) after adjustment. P value 
with Hochberg’s Sharpened Bonferroni correction.
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1.   Finger Tapping Test (FTT): FTT measures the tap-
ping speed of the index finger of each hand [17].
2.   Wechsler Memory Scale-Revised (WMS-R): The 
WMS-R is a substantial revision of the WMS. The subtest 
raw  scores  are  combined  and  the  following  indexed  are   
computed: (1) Verbal Memory Index, (2) Visual Memory 
Index, (3) General Memory Index, (4) Attention/Concentra-
tion Index, and (5) Delayed Recall Index [18]. 
3.   Stroop Color-Word Test (SCWT): A test of execu-
tive functioning, the SCWT requires the patient to inhibit a 
dominant set to read a word in favor of a nondominant set 
to reported the color of ink in which a word is printed [19].
4.   Continuous Performance Test (CPT): The CPT is 
a test of attention. This test requires the patient to rapidly 
respond to sequentially presented stimuli. It assesses (1) sus-
tained attention; and (2) reaction time [20, 21].
Data analyses
Rates and proportion with a two-tailed 95% CI were calcu-
lated for the variables of interest. Wilcoxon matched-pairs 
signed ranks test was used to compare the ages, HAM-D 
scores, and variables of cognitive measurement between pa-
tients and nonpatients. Cross table Chi-square was used to 
compare the sex, education level, and marital status between 
both groups. Factor analysis of the TDQ was performed to 
yield three solutions: the cognitive, affective, and somatic 
factors  (Table  1). The  principal  components  of  HAM-D, 
namely the insomnia/hypochondriasis, anxiety, and core de-
pression factors, were adapted from the study of Samuels 
et al [22]. By using Pearson’s product moment correlation 
coefficient, the correlation between cognitive functions and 
principal components of HAM-D and TDQ was tested with 
partial correlations controlling for age. Furthermore, the cor-
relation  of  difference  in  neurocognitive  performance  and 
difference in TDQ scores after the six-month treatment was 
also tested.  All data were analyzed using the SPSS for Win-
dows package, Release 10.0 [23].
 
Results
Neuropsychological measures for patients and controls 
group
The subjects consisted of 19 patients and 19 controls. In the 
patients group, there were 14 subjects with first episode, and 
5 with relapse or recurrence. The mean episode length was 
13.6 ± 16.1 (mean ± SD) weeks. There was no significant 
difference in age, gender, educational level, or marital status 
between the patient and controls groups (Table 2). 
The  results  indicated  significant  differences  between 
depressed  patients  and  nondepressed  healthy  controls  on 
WMS-R  (Verbal  Memory  Index,  Visual  Memory  Index, 
General Memory Index, and Delayed Recall Index), SCWT, 
and FTT (Table 2). There were no significant differences 
between the two groups in CPT, or Attention/Concentration 










Verbal MEM.I -.50 -.40 -.06 -.30
Visual MEM.I .17 -.07 -.10 -.44
General MEM.I -.49 -.62* .00 -.41
Attention/Concentration I .37 -.01 -.10 .07
Delayed Recall I -.28 -.13 -.01 -.50
FTT
Dominant hand .42 .05 .55 -.57*
SCWT
Test time .14 -.32 .06 -.15
CPT
d’ MASK -.52 -.51 .02 -.46
Table 3. Neurocognitive Performance versus HRSD Scores and Principal Components, Partial Correla-
tion Controlling for Age
*p < 0.05 (two-tailed). aWMS-R: Wechsler Memory Scale–Revised; CPT: Continuous Performance Test; FTT: Finger 
Tapping Test, SCWT: Stroop color-word test. bFactor 1: insomnia/hypochondriasis factor; Factor 2: anxiety factor; Factor 
3: core depression factor.
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Relationships between cognitive deficits and depressive 
symptoms
Factor analyses of the HAM-D and TDQ yielded three so-
lutions, respectively. The cognitive deficit as measured in 
WMSR was correlated with the insomnia/hypochondriasis 
factor of HAM-D; while deficit in FTT was correlated with 
both the anxiety and core depression factors (Table 3). The 
cognitive deficits shown in WMSR Visual Memory Index, 
and SCWT were correlated with somatic factor of TDQ; 
while WMSR Verbal Memory Index and General Memory 
Index were correlated with the affective factor (Table 4). No 
neurocognitive impairment was correlated with the cognitive 
factor of either HAM-D or TDQ.
The  correlation  between  difference  in  neurocognitive 
performance  and  difference  in TDQ  scores  and  principal 
components  after  the  six-month  treatment  are  showed  in 
Table 5. The changes of FTT and WMSR Attention/Concen-
tration Index were correlated with the change in TDQ affec-
tive factor. The changes in FTT, SCWT, and WMSR Visual 
Memory Index, General Memory Index, and Delayed Recall 
Index were correlated with the change in TDQ somatic fac-
tor. The changes in CPT and WMSR General Memory Index 
change were correlated with the change in the total score of 
TDQ. The change in neurocognitive functions was not cor-




Neurocognitive impairment in MDD patients
The present study demonstrates significant neurocognitive 
deficits  in  drug-free  adult  outpatients  with  non-psychotic 
depression,  compared  with  healthy  controls.  The  neuro-
cognitive deficits in MDD patients were found in multiple 
domains, including psychomotor functioning, memory, and 
executive functions. These findings are similar to those of 
previous studies [5, 24, 25], while previous studies reported 
that these abnormalities appear particularly pronounced in 
elderly  patients  and  among  midlife  patients  with  melan-
cholic  or  psychotic  characteristics,  our  findings  indicated 
widespread  neurocognitive  impairments  in  younger  adult 
patients (average age was 33.2 years) with non-psychotic 
MDD. Since our patients were medication free, such trend 
cannot be attributed to the confounding effects of psychotro-
pic medication.   
Do depressed patients perceive their cognitive symptoms 
correctly?
Our data shows that the patients with depression have a wide 
range of neurocognitive impairments compared to normal 
subjects. The neurocognitive deficits in depression are cor-













Verbal MEM.I -.50 -.31 -.78** .33
Visual MEM.I .17 .06 -.07 .68*
General MEM.I -.49 -.39 -.63* .34
Attention/Concentration I .37 .59 -.09 .54
Delayed Recall I -.28 -.08 -.53 .43
FTT
Dominant hand .42 .22 -.08 .63
SCWT
Test time .14 -.11 -.46 .92***
CPT
d’ MASK -.52 -.61 -.58 -.19
Table 4. Neurocognitive Performance versus TDQ Scores and Principal Components, Partial Correla-
tion Controlling for Age
*p < 0.05 (two-tailed);  **p < 0.01 (two-tailed);  ***p < 0.001 (two-tailed). aWMS-R: Wechsler Memory Scale–Re-
vised; CPT: Continuous Performance Test; FTT: Finger Tapping Test, SCWT: Stroop color-word test.
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the cognitive component, of depression rating scales. Fur-
thermore, the changes in neuropsychological measures are 
correlated with the changes in affective and somatic com-
ponents, but not the cognitive component of TDQ. In other 
words, the subjective cognitive symptoms are not correlated 
with the objective measures of neurocognitive impairments. 
Currently, few studies have examined the validity of cogni-
tive symptoms in depressive patients. Even in the context of 
suspected cognitive disorder, the validity of memory com-
plaints is subject to debate [26, 27]. In cross-sectional stud-
ies in elderly adults, memory complaints were associated 
with depressive symptoms [28, 29], but not with their levels 
of cognitive functions or memory performance [26, 27]. In 
contrast, Antikainen et al [30] reported that patients com-
plaining of memory disturbances had higher BDI and HDRS 
scores than patients not complaining, and that they also did 
less well in objective memory performances but not in other 
cognitive functions. However, their sample was character-
ized by chronic inpatients under mediation treatment, which 
was different from ours. 
Taken together, our results suggest that the depressive 
patients  do  not  perceive  their  cognitive  dysfunction  cor-
rectly. The depression rating scales, especially the patient-
administered scale, need to be validated in neurocognitive 
domains for MDD patients in the future, if cognitive compo-
nent is suspected as one of the major domains of self-rating 
scale. 
Generalization of our results must be viewed with cau-
tion considering the outpatient sample, the relatively small 
sample size, increased α-error due to multiple comparison, 
and possible confounding medication effect during follow-
up.
Conclusions
Pronounced  neurocognitive  impairment  was  found  in  our 
sample of adult outpatients with non-psychotic MDD. Since 
this result not attributable to the confounding effects of psy-
chotropic medication, it could therefore serve as an objective 
marker of brain dysfunction in depression. The observation 
that cognitive impairments in depressed patients might cor-
relate with affective or somatic factors, but not with cogni-
tive factor, indicating the tendency of inaccurate report of 
cognitive symptoms in depressed patients. Since the validity 
of the cognitive component of patient-administered depres-
sion rating scale is poor, clinicians may need more objective 
neuropsychological tests to determine the degree of neuro-
cognitive impairments in depressed patients.
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Verbal MEM.I .84 .64 -.11 .91
Visual MEM.I -.66 -.80 -0.11 1.00***
General MEM.I 1.00** -.01 -.89 1.00***
Attention/Concentration I -.13 .28 -1.00*** .63
Delayed Recall I .64 .43 -.50 1.00***
FTT
  Dominant hand .29 -.19 1.00*** 1.00***
SCWT
  Test time .29 .19 -.40 1.00***
CPT
d’ MASK -1.00** -.61 -.58 -.19
Table 5. Change in Neurocognitive Performance versus Change in TDQ Scores and Principal Components, 
Partial Correlation Controlling for Age
*p < 0.05 (two-tailed);  **p < 0.01 (two-tailed);  ***p < 0.001 (two-tailed). aWMS-R: Wechsler Memory Scale-Revised; FTT: Finger 
Tapping Test, SCWT: Stroop color-word test.
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